All Square Wealth Management LLC Nektar Therapeutics Transaction History
All Square Wealth Management LLC
- $176 Million
- Q2 2025
A detailed history of All Square Wealth Management LLC transactions in Nektar Therapeutics stock. As of the latest transaction made, All Square Wealth Management LLC holds 18 shares of NKTR stock, worth $424. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18
Previous 277
93.5%
Holding current value
$424
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NKTR
# of Institutions
22Shares Held
16.1MCall Options Held
17.2KPut Options Held
0-
Black Rock Inc. New York, NY15.2MShares$358 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY491KShares$11.6 Million0.0% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL327KShares$7.71 Million0.0% of portfolio
-
Vista Wealth Management Group, LLC51.5KShares$1.22 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ18.6KShares$438,1810.0% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $4.42B
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...